How To Build Invincible (Pharma) Companies
Source: Life Science Leader
By Alex Osterwalder & Yves Pigneur
Big Pharma has done a fantastic job of managing a portfolio of molecules and chemicals. Heavy investment in R&D has led to some major financial wins for these companies, but to survive and grow, pharma companies have to get better at managing a portfolio of new and existing business models.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more